Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
gptkb:public_company |
| gptkbp:CEO |
Bassil Dahiyat
|
| gptkbp:collaboratesWith |
gptkb:Janssen_Biotech
gptkb:Amgen gptkb:Novartis |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
immuno-oncology
autoimmune diseases antibody therapeutics |
| gptkbp:foundedYear |
1997
|
| gptkbp:founder |
Bassil Dahiyat
Stephen D. Desiderio |
| gptkbp:headquartersLocation |
gptkb:Monrovia,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xencor
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notable_for |
XmAb13676
XmAb14045 XmAb5871 XmAb7195 |
| gptkbp:notableProduct |
XmAb technology
|
| gptkbp:numberOfEmployees |
over 200
|
| gptkbp:platform |
XmAb Fc engineering
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
XNCR
|
| gptkbp:website |
https://www.xencor.com/
|
| gptkbp:bfsParent |
gptkb:Baker_Bros._Advisors
|
| gptkbp:bfsLayer |
7
|